Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 21129608)

  • 1. Adjuvant colon cancer chemotherapy: where we are and where we'll go.
    Lombardi L; Morelli F; Cinieri S; Santini D; Silvestris N; Fazio N; Orlando L; Tonini G; Colucci G; Maiello E
    Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S34-41. PubMed ID: 21129608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
    Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy for localised colon cancer. Fluorouracil + folinic acid for node-positive, non-metastatic disease.
    Prescrire Int; 2011 Feb; 20(113):46-9. PubMed ID: 21488594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adjuvant chemotherapy improves chances of survival in curative surgery of colon cancer, Dukes' stage C].
    Porschen R; Stremmel W
    Z Gastroenterol; 1990 Jul; 28(7):375-6. PubMed ID: 2238769
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
    van Geelen CM; Westra JL; de Vries EG; Boersma-van Ek W; Zwart N; Hollema H; Boezen HM; Mulder NH; Plukker JT; de Jong S; Kleibeuker JH; Koornstra JJ
    J Clin Oncol; 2006 Nov; 24(31):4998-5004. PubMed ID: 17075118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy for colon cancer.
    Ducreux M; Boige V
    Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):283-98. PubMed ID: 11969239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
    Taal BG; Van Tinteren H; Zoetmulder FA;
    Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
    Chua YJ; Zalcberg JR
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):595-604. PubMed ID: 18402526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adjuvant systemic chemo- or immunotherapy of colon cancer].
    Schlag PM
    Chirurg; 1994 Jun; 65(6):503-8. PubMed ID: 8088205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective mismatch repair status as a prognostic biomarker of disease-free survival in stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy.
    Zaanan A; Fléjou JF; Emile JF; Des GG; Cuilliere-Dartigues P; Malka D; Lecaille C; Validire P; Louvet C; Rougier P; de Gramont A; Bonnetain F; Praz F; Taïeb J
    Clin Cancer Res; 2011 Dec; 17(23):7470-8. PubMed ID: 21998335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
    Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
    J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjuvant chemotherapy for colon cancer].
    Dahl O
    Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3094-6. PubMed ID: 18049502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Should adjuvant chemotherapy be also used in Dukes stage B2 colon cancer?].
    Porschen R
    Z Gastroenterol; 1996 Sep; 34(9):549-51. PubMed ID: 8975491
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adjuvant therapy in colon cancer].
    Reinacher-Schick A; Arnold D; Trarbach T; Ridwelski K; Bruch HP; Kirchner T; Kubicka S; Schmoll HJ
    Onkologie; 2010; 33 Suppl 4():2-7. PubMed ID: 20431306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.
    André T; Quinaux E; Louvet C; Colin P; Gamelin E; Bouche O; Achille E; Piedbois P; Tubiana-Mathieu N; Boutan-Laroze A; Flesch M; Lledo G; Raoul Y; Debrix I; Buyse M; de Gramont A
    J Clin Oncol; 2007 Aug; 25(24):3732-8. PubMed ID: 17704423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adjuvant treatment of colonic carcinoma].
    Rochlitz CF; Herrmann R
    Praxis (Bern 1994); 1995 Nov; 84(47):1373-6. PubMed ID: 7501918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New adjuvant therapy for colon cancer: justified hope or commercial hype.
    Galanis E; Alberts SR; O'Connell MJ
    Surg Oncol Clin N Am; 2000 Oct; 9(4):813-23; discussion 825-6. PubMed ID: 11008249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant therapy of colon cancer stage C MAC. Adverse effects and efficacy in the Department of Oncology, Soroka Medical Center in the years 1991-1994].
    Ezekiel G; Walfisch S; Cohen Y
    Harefuah; 1999 Jun; 136(12):923-6, 1004, 1003. PubMed ID: 10955148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current issues in adjuvant treatment of stage II colon cancer.
    André T; Sargent D; Tabernero J; O'Connell M; Buyse M; Sobrero A; Misset JL; Boni C; de Gramont A
    Ann Surg Oncol; 2006 Jun; 13(6):887-98. PubMed ID: 16614880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.